(PharmaNewsWire.Com, August 21, 2018 ) RNAi drug delivery is one among the foremost necessary strategies of analyzing functions in eukaryotes. It conjointly plays an important role in the development of therapeutic gene silencing. Gene silencing is a term that refers to the flexibility of a cell to forestall the expression of a selected Gene. RNAi has application in the areas of medicine, drug delivery, analysis and development and agriculture. The therapeutic application of RNAi includes metabolic disorders, cardiology, neurology, oncology, and medicine.
The global RNAi Drug Delivery Market is estimated to have a value of USD 24.35 billion in 2016. With a CAGR of 27.2%, the market size is expected to grow rapidly to cross USD 81.07 billion by 2021. Increasing analysis activities within the field of ribonucleic acid medicine, growing variety of educational analysis institutes, and increasing prevalence of chronic disorders with respect to internal organ abnormalities and cancer are some of the factors driving the market.
Drivers and Restraints In recent time, increasing prevalence of diseases, especially cancer and vascular diseases, and innovative applications of the drug delivery technologies are a number of the most important drivers of the worldwide RNAi drug delivery market. To Illustrate, aptamer drug delivery technology offers many advantages compared to macromolecule and small-molecule medication, owing to the low risk of side-effects and complications in humans, as well as improved stability and continuance within the blood. In addition, inflated analysis in the field of ribonucleic acid medicine has conjointly driven the expansion of world RNAi drug delivery market. However, high investment price and tight rules are the main restraints for the worldwide RNAi drug delivery market.
Regional Overview North America and Europe dominate the worldwide RNAi drug delivery market. This can be because of the improved bioscience analysis infrastructure in these regions. The U.S. represents the most important marketplace for RNAi drug delivery technologies followed by European countries such as France, Germany, and U.K. On the other hand, Asia Pacific is predicted to indicate high growth rates within the next 5 years in the RNAi drug delivery market because of the enhanced investment by major corporations in the region.
The major market contributors for the global RNAi Drug Delivery Market are Alnylam Pharmaceuticals Inc., Merck & Co. Inc, Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals Inc, Calondo Pharmaceuticals Inc., Marina Biotech Inc., RXi Pharmaceuticals Corp., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Traversa Therapeutics Inc., Tacere Therapeutics Inc., Sirnaomics Inc., and PhaseRx Inc.
About MarketDataForecast™ Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions
Contact Info: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
